Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
| 2 | Dexmedetomidine 1 | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 💬
|
| 3 | Dexmedetomidine 2 | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 💬
|
| 4 | Dexmedetomidine 3 | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 💬
|
| 5 | Dexmedetomidine group | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
| 6 | Dexmedetomidine Hcl 100 Mcg/mL Inj | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 💬
|
| 7 | DEXMEDETOMIDINE HYDROCHLORIDE | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
| 8 | Dexmedetomidine Hydrochloride Infusion | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 💬
|
| 9 | Dexmedetomidine injection | 1件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine) | 2件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE) 💬 | 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
| 10 | Dexmedetomidine with ropivacaine | 2件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine),Ropivacaine | 4件: Dexmedetomidine
Dexmedetomidine
(Dexmedetomidine),Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE), Ropivacaine hydrochloride , Ropivacaine 💬 | 9件: ADRA2A ADRA2A,ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, Hormone signaling, IgSF CAM signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 💬
|
| 11 | DexmedetomidineProduct Name: DexdorPharmaceutical Form: Concentrate and solvent for solution for infusionINN or Proposed INN: DEXMEDETOMIDINECAS Number: 113775-47-6Pharmaceutical form of the placebo: Concentrate and solvent for solution for infusionRoute of administration of the placebo: Intravenous use | - | - | - | - | 1件: 70 70 💬
|
| 12 | Fentanyl (Low Dose) + Dexmedetomidine | 2件: Dexmedetomidine Dexmedetomidine (Dexmedetomidine),Fentanyl | 5件: Fentanyl
Fentanyl
,Dexmedetomidine (Dexmedetomidine), Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE), Fentanyl citrate , Fentanyl hydrochloride 💬 | 4件: ADRA2A ADRA2A,ADRA2B, ADRA2C, OPRM1 💬 | 6件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 💬
|
| 13 | Scopolamine, atropine, edaravone and dexmedetomidine | 4件: Atropine Atropine,Dexmedetomidine (Dexmedetomidine), Edaravone, Scopolamine | 7件: Atropine
Atropine
,Scopolamine , Dexmedetomidine (Dexmedetomidine), Dexmedetomidine hydrochloride (Dexmedetomidine hydrochloride, DEXMEDETOMIDINE, DEXMEDETOMIDINE HCL, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE), Edaravone , Atropine sulfate , Scopolamine hydrobromide 💬 | 8件: ADRA2A ADRA2A,ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 16件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Hormone signaling, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 💬
|